The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 Diabetes.
Diabetes Care
; 45(6): 1408-1415, 2022 06 02.
Article
in En
| MEDLINE
| ID: mdl-35312749
Full text:
1
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Sodium-Glucose Transporter 2 Inhibitors
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Year:
2022
Type:
Article